Cortisol levels, motor, cognitive and behavioral symptoms in Parkinson’s disease: a systematic review Nayron Medeiros SoaresGabriela Magalhães PereiraCarlos R. M. Rieder Neurology and Preclinical Neurological Studies - Review Article 29 October 2018 Pages: 219 - 232
Dementia spectrum disorders: lessons learnt from decades with PET research Heather WilsonGennaro PaganoMarios Politis Neurology and Preclinical Neurological Studies - Review Article Open access 14 February 2019 Pages: 233 - 251
Hand, foot, and spine deformities in parkinsonian disorders Subhashie WijemanneJoseph Jankovic Neurology and Preclinical Neurological Studies - Review Article 27 February 2019 Pages: 253 - 264
The role of neurotrophins in psychopathology and cardiovascular diseases: psychosomatic connections Andrea LászlóLilla LénártJános Nemcsik Psychiatry and Preclinical Psychiatric Studies - Review Article Open access 14 February 2019 Pages: 265 - 278
Dopaminergic denervation using [123I]-FPCIT and pain in Parkinson’s disease: a correlation study Estelle DellapinaJean PellapratChristine Brefel-Courbon Neurology and Preclinical Neurological Studies - Original Article 31 January 2019 Pages: 279 - 287
Long-term safety and efficacy of adjunctive rasagiline in levodopa-treated Japanese patients with Parkinson’s disease Nobutaka HattoriAtsushi TakedaRyosuke Takahashi Neurology and Preclinical Neurological Studies - Original Article Open access 11 January 2019 Pages: 289 - 297
Long-term, open-label, phase 3 study of rasagiline in Japanese patients with early Parkinson’s disease Nobutaka HattoriAtsushi TakedaRyosuke Takahashi Neurology and Preclinical Neurological Studies - Original Article Open access 28 January 2019 Pages: 299 - 308
Longterm outcome of cognition, affective state, and quality of life following subthalamic deep brain stimulation in Parkinson’s disease Doreen GruberLisa CalmbachAndreas Kupsch Neurology and Preclinical Neurological Studies - Original Article 25 January 2019 Pages: 309 - 318
Association between physical activity and dementia’s risk factors in patients with Parkinson’s disease Mohammad AlwardatTommaso SchirinziAntonio Pisani Neurology and Preclinical Neurological Studies - Original Article 12 February 2019 Pages: 319 - 325
Comparison of clinical and neuropathological diagnoses of neurodegenerative diseases in two centres from the Brains for Dementia Research (BDR) cohort Sashika SelvackaduncoKatie LangfordSafa Al-Sarraj Neurology and Preclinical Neurological Studies - Original Article Open access 07 February 2019 Pages: 327 - 337
Validation of a prototype tau Thr231 phosphorylation CSF ELISA as a potential biomarker for Alzheimer’s disease Joana R. F. SantosChris BauerJonathan Vogelgsang Neurology and Preclinical Neurological Studies - Original Article 14 February 2019 Pages: 339 - 348
The first identification of nesfatin-1-expressing neurons in the human bed nucleus of the stria terminalis Artur PałaszKatarzyna BogusRyszard Wiaderkiewicz Psychiatry and Preclinical Psychiatric Studies - Short communication Open access 15 February 2019 Pages: 349 - 355